PharmaShots | Incisive News in 3 Shots

Subscribe Now

IDEAYA Biosciences

IDEAYA Biosciences Partners with Hengrui Pharma to Develop SHR-4849 for Treating SCLC and NET Solid Tumors

IDEAYA Biosciences Partners with Hengrui Pharma to Develop SHR-4849 for Treating SCLC and NET Solid Tumors

December 30, 2024

IDEAYA Biosciences Nominates IDE034 as a Development Candidate Under Partnership with Biocytogen

IDEAYA Biosciences Nominates IDE034 as a Development Candidate Under Partnership with Biocytogen

November 11, 2024

IDEAYA Biosciences Collaborates with Biocytogen to Develop Bispecific ADC Program for Cancer Treatment

IDEAYA Biosciences Collaborates with Biocytogen to Develop Bispecific ADC Program for Cancer Treatment

July 31, 2024

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us